Life-science briefing: Tuesday, March 25, 2008
TODAY’S HEADLINES:
Antibody-discovery startup Adimab raises new funding (release)
Lung-device maker Spiration gets $19M (release)
Sample-prep startup Protein Discovery pulls in $10M (release)
Inogen takes in $13M for portable oxygen device (VentureWire)
Healthcare IT concern Medaptus raises $11M for expansion (VentureWire)
Contract lab Synexis raises $14M (peHUB)
Medical-device VC firm BioStar Ventures takes… Continue Reading
Life-science briefing: Tuesday, March 18, 2008
TODAY’S HEADLINES:
Luminous Medical raises $24M for automated glucose monitoring (release)
Alimera Sciences gets $30M for eye-disease drug (release)
Vaccine maker LigoCyte draws $28M (release)
Heartbeat tracker CardioNet trims IPO, aims for listing today (IPOhome)
Axial Biotech takes in $6M for spinal diagnostics (release)
Insulin bioengineer enGene receives $6.4M (release)
GlucoLight raises… Continue Reading
Life sciences briefing: Wednesday, March 5, 2008
TODAY’S HEADLINES:
Precision Thera merger with “blank check” Oracle Healthcare collapses (release)
Sleep Solutions takes in $21M for sleep-apnea diagnostics (release)
Trevena takes in $24M for drugs targeting G-proteins (release)
“Specialty biotech” PanGenetics gets €23M for antibody drugs (release)
Cancer-drug maker Unibioscreen pulls in €5M (release)
Danish contract manufacturer CMC Biologics… Continue Reading
PublicEarth raises $3M for GPS data directory
PublicEarth seems to be a little different from the various other GPS and location-based startups currently swarming the scene, although the company is currently in stealth.
According to an article from CommerceNet, written over a year ago, the company is building a directory of data for… Continue Reading
Life sciences briefing: Monday, Feb. 4, 2008
TODAY’S HEADLINES:
PEAK Surgical takes in $21M for electrosurgical tools (release)
CellGate acquired by Australian cancer biotech ProGen for $2.5M (release)
Traversa raises $2M for RNAi-delivery technologies (release)
RemitDATA, Web-based healthcare-service co., takes in $5.5M (bizjournals.com)
Spinal-implant maker Archus Orthopedics gets $10M venture loan (release)
Promedior pulls down another $5.5M for… Continue Reading
Health-info site HealthCentral Network pulls in $50M
(UPDATED: IAC put out a release this morning — see below.)
The HealthCentral Network, an Arlington, Va., collection of health-information sites, raised roughly $50 million, paidContent reports. Investors included some big names, include Barry Diller’s online media and commerce conglomerate IAC, Sequoia Capital, Carlyle Group and Polaris… Continue Reading
Spurning purchase offers, Automattic raises round and partners with NYT
Automattic, the company that owns the popular Wordpress blogging software platform, has raised $29.5 million from existing investors and a new partner, the New York Times. Some companies had offered to buy it, founder Matt Mullenweg writes.
The San Francisco company started out as an open… Continue Reading
Web traffic measurement company Quantcast raises $20M more
Quantcast, the company that places a piece of code on Web sites so that it can track traffic and other data directly, has raised $20 million more in financing.
The round was led by the Founders Fund and included Polaris Venture Partners. It follows $6 million… Continue Reading
LIfe sciences briefing: Tuesday, Jan. 15, 2007
TODAY’S HEADLINES:
Pervasis Thera pulls in $9.8M for regenerative medicine (release)
Embrella Cardio receives $2.3M for stroke-prevention heart-surgery devices (release)
Vivendy Thera raises CHF 17M for rare-disease drug (Private Equity Europe)
Novacta Bio gets £3.5M grant for anti-infective drugs (release)
Metavante acquires health-plan admin software co. Bensoft (release)
Pharma-marketing analyst ImpactRx… Continue Reading
ARPU takes $8.7M for point-of-sale advertising
ARPU bills itself as an advertising network that adds value for businesses by offering additional services to buyers at the time of an online sale.
For instance, a consumer buying an internet access package from a service provider might be offered relevant add-ons like phone service… Continue Reading
Life sciences briefing: Thursday, Jan. 3, 2008
TODAY’S HEADLINES:
Gelesis draws in $16M for obesity treatments (release)
Tempo Pharma raises $8B for nanoparticle drugs (release)
Calistoga Pharma receives additional $5M for cancer and inflammation drugs (release)
Montreux Equity Partners closes $250M life-sciences fund (release)
MTS Health Partners names Andrew Weisenfeld, Mark Epstein managing directors (release)
T2 Biosystems names… Continue Reading
Life sciences briefing: Wednesday, Dec. 19, 2007
TODAY’S HEADLINES:
Gene-silencing developer Santaris raises €20M (PDF release)
Consumer-driven healthcare manager RedBrick Health prescribed $15M (release)
Cardiac Dimensions takes in $36M for heart-valve device (release)
TcLand Expressions gets €8.2M for biomarkers (PDF release)
TheraQuest Bio gets $3M for pain drugs (release)
Brain-software maker NeuroTrax visualizes $1.5M (VentureWire)
ActivBiotics selling off assets… Continue Reading
Life sciences briefing: Friday, Nov. 30, 2007
Featured companies: Fate Therapeutics, Medgenics, Satoris
UPDATED: Expanded items on Fate Therapeutics and Medgenics. The Satoris item is now a standalone post here.
Fate Therapeutics launches regenerative-medicine quest with $12M — In one of the splashiest launches in recent memory, Seattle’s Fate Therapeutics launched a new regenerative-medicine quest and… Continue Reading
BlackArrow inserts ads for cable companies, raises $12M
BlackArrow, a San Mateo, Calif., startup, is offering a new technology to help keep TV advertisers happy.
The company, in secrecy until now, will announce tomorrow (Monday) that it wants to insert targeted ads into on-demand viewing by placing a piece of hardware between cable operators… Continue Reading
Life sciences briefing: Monday, Oct. 1, 2007
Featured companies: Abiant, CellXplore, Diffusion Pharmaceuticals, WMR Biomedical, Zosano Pharmaceuticals
Diffusion Pharma raises $4.5M for vascular-disease and brain-cancer drug — Charlottesville, Va.-based Diffusion Pharmaceuticals, a biotech focused on drugs that enhance oxygen diffusion, raised $4.5 million in a private placement. Angel investors provided the funding, which brings… Continue Reading
Zink offers inkless printing, raises $25M
Saying it has perfected technology that allows it to print without using any ink, Zink’s next move will be to use $25 million recently raised from Petters Group Worldwide to manufacture its initial inventory.
The Boston-area company revealed its product, a printer-and-paper combination, at last January’s… Continue Reading
Life sciences briefing: Wednesday, Sept. 5, 2007
Featured companies: Atritech, Avalon Partners, Ensemble Discovery, Hyperion Therapeutics, LifeBond, ReShape Medical, SafeStitch, Trophos, UltraShape
Hyperion Therapeutics raises $40M against GI and kidney disease — Hyperion Therapeutics, a South San Francisco, Calif., specialty pharmaceutical company, raised $40 million in a second funding round. Investors included Sofinnova Ventures,… Continue Reading
Life sciences briefing: Monday, Aug. 20, 2007
(UPDATED at 7:10pm PT: See below.)
Featured companies: NeurAxon, VytronUS, Avila Therapeutics, CardioNet, Ventana Medical Systems, CytoLogix, PlaCor
NeurAxon raises $32M for pain drugs — You have to hand it to Waltham, Mass.-based NeurAxon — the company certainly knows how to keep itself in the news. Today, it announced… Continue Reading
Life sciences briefing: Thursday, Aug. 9, 2007
(UPDATED at 6:40pm PT: See below.)
Featured companies: Nereus Phramaceuticals, KFx Medical, NeuroMed Pharmaceuticals, Adnexus Therapeutics, Masimo, Biofisica, Aegera Therapeutics, LymphoSign, InfuScience, Palmetto Infusion Services
Nereus Pharma raises $45M for ocean-derived cancer drugs — San Diego’s Nereus Pharmaceuticals, a biotech that searches for cancer drugs in marine microbes, raised… Continue Reading
Adimab: A potential one-stop shop for antibodies
Adimab, a Lebanon, N.H., biotech startup developing a “platform” for the discovery and commercialization of yeast-derived antibodies, raised $6 million in a first funding round (hat tips to the In Vivo Blog and VentureWire). The company was founded by Darthmouth’s Tillman Gerngross — who co-founded… Continue Reading